1981C>T allele
1981C>T mutation
4/6-PI3K inhibition
5A H3
5A histone
acid LXCXE
activation AhR
activation autophagy
activation biogenesis
activation genes
activation inhibition
activation mechanisms
activation p21
activation Rb
activation signaling
activation tumor
activator c-Myc
Additionally RB/Rb
adhesion alpha
Adhesion assays
adhesion HUVEC
adhesion ICAM-1
adhesion L-selectin
adhesion molecule
adhesion trophoblast
AhR CDK4
AhR cyclin
AhR CYP1A1
AhR FICZ
AhR immunofluorescence
AhR ligand
Akt FOXOs
Akt phosphorylation
Akt targets
alleles RB1
alleles tumor
allele suppressor
allele tumor
alpha alpha
alpha beta
alpha IIb
Alteration p16
analyses tissue
analysis FICZ
analysis RNA
analysis TBLR1
and/or OGA
aneuploidy binucleation
antigen-1 ICAM-1
antigen-1 lymphocytes
aortic constriction
apoptosis activation
apoptosis emergence
apoptosis gene
apoptosis MAPK
apoptosis murine
apoptosis pRb/E2F1
apoptosis retina
apoptosis retinoblastoma
apoptosis senescence
apoptosis sensitivity
apoptosis tumor
Arg661Trp allele
Arg661Trp mutation
Arg661Trp tumor
arrests cycle
arterioles venules
assay analysis
assay cytometric
assay cytometry
assay immunoprecipitation
assay promoters
assay proteins
Aurora down-regulation
Aurora inhibition
Aurora inhibitors
Aurora stabilization
autophagy cancer
autophagy tumor
behavior osteosarcoma
behavior outcomes
behavior subtype
beta adhesion
beta alpha
beta ICAM-1
binucleation tetraploidy
bioinformatic analyses
BrdU assay
BrdU incorporation
BYL719 pRB
Caenorhaditis elegans
cancer AhR
cancer cyclin
cancer D1-transactivation
cancer mutations
cancer patients
cancer phenotype
cancer progression
cancer radiation
cancers cancer
cancers phosphorylation
cancers RB
cancers sensitivity
cancer strategy
cancer therapy
cancer tissue
cancer tissues
cancer vitro
cancer X-ray
% carcinoma
cardiomyocyte hypertrophy
cardiomyocytes inhibition
cardiomyocytes miR-16
carriers tumors
CD11a/CD18 ICAM-1
CD11a/CD18 interactions
CD56+ lymphocytes
CDC25A HDAC1
CDC25A oncogene
CDK2 P27
CDK2 pRb
CDK 4/6-PI3K
CDK4 CDK2
CDK4 cyclin
CDK4 D1
Cdk4 pRb
Cdk4 upregulation
CDK inhibition
CDK inhibitors
CDK Rb
CDK sites
Cells Rb1
Cellular iPSCs
Cellular kinase
Cellular Rb
chromatin gene
chromosome aneuploidy
chromosome missegregation
Chx10-Cre Rbl1
CNE-1 CNE-2
CNE-1-scramble downregulation
CNE-1-scramble SHP-1
CNE-1-scramble shRNA
CNE-2 lentiviruses
coactivator Kdm5a
coactivator target
co-altered RB/E2F
colon cancer
colon Rb
compartment culture
compartment tissue
complexes transcription
complex NORE1A
consensus CDK
consensus promoters
consensus Rb
consensus sequences
consensus sites
contacts E2F
contacts transcription
correlation p16
co-treatment CH223191
CpG85 intron
C-terminal IE
C-terminal Rbf1
cycle analysis
cycle apoptosis
cycle Aurora
cycle CDC25A
cycle colon
cycle correlation
cycle differentiation
cycle DU-145
cycle E2F-4
cycle E2F-responsive
cycle exit
cycle LoVo
cycle oncogene
cycle progression
cycle proteins
cycle regulator
cycle senescence
cycle suppressor
cycle tissues
cycle transition
cycle tumor
cyclin activation
cyclin CDK2
cyclin D1
cyclin D1-transactivation
cyclinD1 up-regulation
cyclin P27
cyclins D1
Cyclins D1
cyclins D2
Cyclins D2
cyclins E1
Cyclins E1
cyclin signaling
Cyclins/retinoblastoma protein
CYP1A1 CDK4
CYP1A1 cyclin
cytomegalovirus protein
cytomegalovirus UL97
cytometric analysis
D1 D2
D1 E1
D1 phosphorylation
D1 signaling
D1-transactivation activation
D2 E1
D326V missense
D326V pRb
data adhesion
data deregulation
data phospho-Rb
data pRb
data UL97
decrease proteins
defense tumorigenesis
deffect inactivation
deletion p130
deletion Pten
deletion Rb
demethylase 5A
demethylase histone
deregulation RB-E2F
deregulation retinoblastoma
DFS analysis
differential methylation
differentiation KDM5A
differentiation mechanisms
differentiation tumor
diploid fibroblast
diploid WI-38
discoid tumors
disruption complexes
disruption Rb-E2F
DNA deacetylase
DNA histone
DNA methylation
DNA methyltransferase
DNMT1 DNMT3b
downregulates CDC25A
downregulates cycle
downregulates regulator
down-regulation cyclinD1
down-regulation E2F-mediated
downregulation senescence
down-regulation transcription
down-regulation up-regulation
downstream TGFβ
Drosophila Caenorhaditis
Drosophila elegans
Drosophila protein
Drosophila Rbf1
drug PIK3CA
dysfunction gene
E1 pRb
E2F1-deficient fibroblasts
E2F1 E2F
E2F1 E2F2/3
E2F1 Ogt
E2F1 OGT
E2F1 Rb1-deficient
E2F1 retinoblastoma
E2F complex
E2F consensus
E2F constructs
E2F-dependent gene
E2F gene
E2F impact
E2F-mediated transcription
E2F Myb
E2F reporter
E2F-responsive gene
E2F-responsive transcription
E2F sequences
E2F sites
E2F transcription
E3 ligase
E3 ligases
E3 protein
E3 RB
E3 ubiquitin
E6 E7
E6 oncoproteins
E7 oncoproteins
Ectopic RB
effectiveness patients
effectiveness therapy
effector NORE1A
electroporation retinas
elongation p21
elongation RNA
endogenous AhR
endogenous ligand
Endothelium alpha
ER HER-2
ER Ki-67
ER PR
Expression p16
Expression pRb
Expressions cyclins
Expressions D1
Expressions D2
fibroblasts levels
fibroblasts Ogt
fibroblast WI-38
FICZ AhR
FICZ endogenous
FICZ ligand
FICZ proliferation
findings contexts
findings data
findings NORE1A
findings sirtinol
findings TGFβ
Fishers test:
fluorescent hybridization
fluorescent situ
follicular hyperplasias
FOXOs mediators
frequency co-altered
fucoidan genes
fucoidan HepG2
Fucoidan HepG2
fucoidan INK4a
fucoidan locus
fucoidan tumor
fundus OCT
fundus photographs
Furthermore downregulates
Furthermore lobe
Furthermore p16
Furthermore Rb
Furthermore upregulation
G0/G1 complexes
G2/M apoptosis
gene disruption
gene mutagenesis
gene osteosarcoma
gene penetrance
gene profiling
gene Rb
genes apoptosis
genes p21
genes RB1
genes RBL1
genes RBL2
glands alpha
glands integrins
glycoproteins outgrowth
H3K9Me3 CDK4
H3K9Me3 cyclin
H3K9Me3 D1
H3K9Me3 HP1γ
H3 Lys4
haploinsufficiency tumorigenesis
HCV HuH-7-CORE
HCV protein
HEK293 E2F1
hepatocellular carcinoma
HepG2 fucoidan
HepG2 viability
HER-2 fluorescent
HER-2 Ki-67
histone deacetylase
histone H3
histone Lys4
HNSCC pathogenesis
HNSCC progression
homeostasis retinoblastoma
homeostasis tumor
HP1γ CDK4
HP1γ cyclin
HP1γ D1
HPyV7 phospho-Rb-
HPyV7 thymomagenesis
HuH-7-CORE analysis
HuH-7-CORE cycle
HuH-7-CORE promoter
Human diploid
Human fibroblast
Human WI-38
HUVEC adhesion
HUVEC layer
hybridization HER-2
hydrocarbon receptor
hyper-methylation up-regulation
hyperplasias pRb
hypertrophic cardiomyocytes
hypertrophic myocardium
hypertrophy cyclins
hypertrophy inhibitions
hypertrophy phenotype
ICAM-1 endothelium
ICAM-1 interactions
ICAM-1 L-selectin
ICAM-1 VCAM-1
IE mutations
IE protein
IE Rbf1
IE turnover
imaging modality
immunocytochemistry PCR
immuno-histochemistry thymomas
immunoprecipitation techniques
immunosenescence outcomes
impact kinase
impact protein
impact repression
impact turnover
Importantly NRBE3
inactivation alleles
inactivation E2F
inactivation E2F1
inactivation p53
inactivation phosphorylation
inactivation Rb-E2F
incorporation assay
incorporation cytometry
indicator survival
inhibition Aurora
Inhibition Aurora
inhibition Cdk4
inhibition cycle
inhibition miR-16
inhibition p53
inhibition pRb
inhibition progression
inhibition senescence
inhibition viability
inhibitor BYL719
inhibitor kinases
inhibitors Aurora
inhibitors cancers
inhibitors CDK
inhibitors recruitment
inhibitors therapy
inhibitory TGFβ
INK4a genes
INK4a locus
integrins lymphocytes
integrins membrane
interaction inhibitors
interaction p27
interactions E3
interaction Skp2/Cks1
interactions ligases
intraocular inactivation
intraocular neoplasm
intron RB1
involvement modifier
ionizing radiation
KDM5A 5A
KDM5A activation
Kdm5a deletion
KDM5A deletion
KDM5A demethylase
Kdm5a differentiation
Kdm5a genes
Kdm5a repressor
Kdm5a target
Ki67 0
Ki-67 fluorescent
Ki67 labeling
Ki-67 situ
kinase inactivation
kinase Rb
kinase Rbf1
KI tumorigenesis
L1 motif
L1 UL97
labeling 0
laboratory assays
levels HuH-7-CORE
levels Mgea5
levels Ogt
Levels p21
Levels p53
levels pRB
ligase RB
ligases protein
lobe pituitary
locus apoptosis
locus genes
LoVo cancer
LoVo colon
lung tumors
LXCXE motif
LXCXE RB
LXCXE UL97
lymphocytes ICAM-1
Lys4 protein
Lys-774 phenotypes
Lys-774 residue
malignancies cancer
malignancies prostate
MAPK elongation
MAPK HepG2
matrix components
maturation TGFβ
mechanisms diseases
mechanisms Ras
mechanisms Rb
mechanisms ROS
mechanisms senescence
MED4 analyses
MED4-driven MED4
MED4-driven methylation
MED4 methylation
mediators apoptosis
mediator types
membrane components
methylation analyses
methylation DNA
methyltransferase deacetylase
methyltransferase histone
Mgea5 genes
Mgea5 overexpression
Mgea5 Rb1
Micron imaging
miR-16 phenotype
miR-16 target
miR-449a cycle
miR-449a G2/M
miRNAs hypertrophy
missegregation aneuploidy
missense E2F1
missense pRb
mitochondria oxygen
mitotic kinase
modifier gene
modifier penetrance
molecule ICAM-1
molecule inhibitors
molecule recruitment
motif RB
motif UL97
motility se
mRNA HuH-7-CORE
mRNA levels
murine Rb/p107
murine retina
mutation codon
mutation penetrance
mutations gene
Mutations oncogene
Mutations Ras
mutations retinoblastoma
mutations sites
mutations turnover
Myb complex
myocardium cardiomyocytes
neoplasm inactivation
network type-specific
node Ras
nonresponding tumors
nontumor tissues
NORE1A PP1A
NORE1A Ras
NORE1A role
NORE1A senescence
NRBE3 cycle
NRBE3 LXCXE
NRBE3 motif
NRBE3 RB
NRBE3 ubiquitination
OCT imaging
O-GlcNAc O-GlcNAcase
O-GlcNAc transferase
OGT and/or
Ogt genes
Ogt Mgea5
OGT MGEA5
OGT OGA
OGT/OGA protein
oncogene HDAC1
oncoprotein cancers
osteosarcoma gene
osteosarcoma profiling
outcomes adults
overexpression E2F1
over-expression HCV
overexpression inhibition
Overexpression KDM5A
overexpression miR-449a
Overexpression miR-449a
Overexpression Pgc-1α
overexpression TBLR1
oxygen MAPK
oxygen p38
p130 repression
p16 <
p16 p53
p16 pRB
p16 thymic
p21 Aurora
p21 inhibition
p21 p53
p21 Pol
p21 proliferation
p21 RNA
P27 pRb
p27 Skp2/Cks1
p27T187A KI
p27T187A tumorigenesis
p27 tumor
p38 MAPK
p53 Aurora
p53 inhibition
p53 p21
p53 Rb
p53 suppressor
p53 tumor
papillomavirus E6
papillomavirus E7
papillomavirus oncoproteins
pathologic cis
patients NPC
patients TBLR1
patients tumors
PC-3 miR-449a
PC-3 overexpression
PC-3 pRb/E2F1
penetrance alleles
penetrance expressivity
penetrance Fishers
penetrance mutations
penetrance pedigrees
penetrance Rb
penetrance tumors
peptides acid
Pgc-1α 1α
Pgc-1α deletion
Pgc-1α KDM5A
Pgc-1α proliferator-activated
Pgc-1α receptor
phenotype cardiomyocytes
phenotypes Drosophila
phospho-Rb p16
phosphorylation complexes
phosphorylation FOXOs
phosphorylation mutation
phosphorylation protein
phosphorylation Rb-E2F
phosphorylation sites
phosphorylation targets
phosphorylation Thr-187
photographs OCT
PI3K BYL719
PI3K cancers
PI3K CDK
PI3K inhibitor
PI3K inhibitors
PIK3CA cancers
PIK3CA xenografts
pituitary inactivation
pituitary thyroid
pituitary tumors
positivity PR
potentials inhibitors
potentials interaction
potentials Skp2/Cks1-p27T187p
PP1A activation
pRB cancer
pRb CDK4
pRB cycle
pRb differentiation
pRb E2F1
pRb/E2F1 cancer
pRb/E2F1 prostate
pRb H3K9Me3
pRb HP1γ
pRb hypertrophic
pRb inactivation
pRB nonresponding
pRb p16
pRb phospho-Rb
pRb pRb2/p130
pRb protein
pRb Rb
pRBs differentiation
pRBs role
pRB tumors
pRb upregulation
Previously protein
PR HER-2
PR Ki-67
PR negativity
progenitor Chx10-Cre
prognostic gene
prognostic marker
progression apoptosis
progression cancer
progression E2F-responsive
progression senescence
progression transcription
proliferation activation
proliferation apoptosis
proliferation physiology
proliferation transcription
proliferation tumorigenicity
proliferator-activated 1α
proliferator-activated receptor
promoter hyper-methylation
promoter methylation
promoter Ogt
prosenescent retinoblastoma
prosenescent tumor
prostate cancer
prostate X-ray
protein activation
protein CDK
protein chromatin
protein contacts
protein impact
protein interactions
protein levels
protein mRNA
protein p16
protein pRb
protein pRBs
protein products
protein protein
protein proteins
protein Rb
protein Rbf1
protein role
protein roles
proteins correlation
proteins implications
proteins p16
proteins pRb
proteins proteins
proteins Rb
proteins stability
protein tumorigenesis
protein tumors
protein turnover
protein UL97-L1m
proteomic analyses
Pten Rb1
Pten Rbl1
pyruvate oxidation
radiosensitivity assay
radiosensitivity PC-3
Ras effector
Ras NORE1A
Ras oncogene
Ras p53
RB1 carriers
Rb1-deficient fibroblasts
RB1 DNA
Rb1 E2F1-mediated
RB1 gene
RB1 humans
RB1 inactivation
Rb1 knockout
Rb1 mitochondria
Rb1 modeling
Rb1 pituitary
Rb1 Pten
Rb1 Rbl1
RB1 RBL1
RB1 RBL2
RB1 suppressor
RB1 tumor
Rb1 tumors
Rb activation
Rb assays
Rb CDK4
RB complex
Rb cyclin
Rb-dependent RNA
Rb dephosphorylation
Rb DU-145
RB E2F
Rb/E2F apoptosis
Rb-E2F complexes
RB-E2F dysfunction
RB-E2F gene
Rb/E2F-induced apoptosis
RB/E2F PTEN/PI3K/AKT
Rb-E2F transcription
RB E3
Rbf1 proteins
Rbf1 turnover
Rb H3K9Me3
Rb HP1γ
Rb inactivation
Rbl1 progenitor
RBL1 promoter
RBL1 RBL2
RBL2 methylation
RBL2 promoter
RBL2 RBL2
RB ligase
Rb mutations
RB Myb
Rb NORE1A
Rb overexpression
Rb/p107 apoptosis
Rb/p107 Rb/E2F
Rb p130
Rb p16
Rb p53
Rb PC-3
Rb penetrance
Rb peptides
Rb phosphorylation
RB phosphorylation
Rb protein
RB proteins
Rb radiosensitivity
Rb Rb
Rb/RB1 mutation
RB/Rb pyruvate
Rb senescence
Rb suppressor
Rb tissues
Rb transfection
Rb tumor
RB tumor
Rb tumors
RB ubiquitin
RB ubiquitination
Rb UL97-mediated
RB vitro
reactive oxygen
reactive p38
receptor 1α
receptor proliferation
reconstitution assay
reconstitution proteins
recruitment Thr-187-phosphorylated
regressions PIK3CA
regressions xenografts
regulator CDC25A
regulator HDAC1
regulator oncogene
regulator Pgc-1α
regulator proliferator-activated
regulator receptor
regulators cycle
relevance mechanisms
replication qPCR
reporter assay
reporter constructs
repression constructs
repression deffect
repression E2F
repression pRb
repression reporter
repression Sox2
repressor differentiation
repressor genes
repressor Sox2
reprogramming impact
residue phenotypes
residues C-terminal
residues IE
resveratrol activator
retention stroma
retina Rb/p107
retinoblastoma corepressors
retinoblastoma emergence
retinoblastoma gene
retinoblastoma pRb
retinoblastoma promoter
retinoblastoma protein
retinoblastoma proteins
retinoblastoma suppressor
retinoblastoma tumor
RNA Pol
role cycle
role deletion
role differentiation
role ionizing
role Kdm5a
role oncoprotein
role proliferation
role RB-E2F
roles differentiation
role senescence
roles hypertrophy
roles tumor
role TBLR1
role transformation
SCF ligase
SCF ubiquitin
segregation chromosomes
senescence cycle
senescence differentiation
senescence hepatic
senescence Ras
senescence role
senescence ROS
senescent phenotype
sensitivity inhibitors
sensitivity PI3K
sensitivity radiation
sensitivity X-ray
sequences promoters
S/G2 complex
SHP-1 downregulation
SHP-1 overexpression
SHP-1 role
shRNA Akt
shRNA downregulation
shRNA SHP-1
ShRNAs vitro
signaling cancer
signaling retinoblastoma
Significantly activation
sites Ogt
sites promoters
sites Rb
situ HER-2
situ hybridization
Skp2/Cks1-p27T187p inhibitors
Skp2/Cks1-p27T187p interaction
Skp2/Cks1 susceptibility
Skp2/Cks1 tumor
Sox2 deffect
Sox2 differentiation
Sox2 Rb
Sox2 tumor
Specifically E2F1
spectrum incidence
squamous carcinoma
stability proteins
stabilization p53
staining E-selectin
Statistical analyses
Strikingly IE
Strikingly mutations
stromal glands
Studies resveratrol
subgroups cancer
subset genes
subtype outcomes
subtypes gene
subtypes osteosarcoma
suppressor cycle
suppressor dephosphorylation
suppressor gene
suppressor node
suppressor pRb
suppressor progression
suppressor promoter
suppressor protein
suppressor Ras
suppressor repressor
suppressor retinoblastoma
suppressor roles
suppressors factors
Surprisingly NRBE3
survival cancer
survival patients
susceptibility proliferation
target genes
target hypertrophy
targets FOXOs
TBLR1 overexpression
TBLR1 proliferation
TBLR1 role
TBLR1 survival
TBLR1 TBLR1
TBLR1 tumorigenicity
TCA cycle
TCA tissues
TGFβ activation
TGFβ autophagy
TGFβ cytokine
TGFβ tumor
therapeutics factors
therapy cancer
therapy patients
therapy strategy
Thr-187-phosphorylated SCF
Thr-187-phosphorylated ubiquitin
threonine residue
% thymic
thymic carcinoma
thymic tumors
thymomas %
thymomas carcinomas
thymomas thymic
thyroid tumors
tissue culture
tissue E2F1
tissue nontumor
tissues decrease
Tracking tumor
transcription S/G2
transcription sites
transducer activator
transfection assays
transferase O-GlcNAcase
transformation cancer
transformation HCV
transverse aortic
transverse constriction
trigger E2F/FOXO
trophoblast vitro
trophoblast vitronectin
tumor behavior
tumor cycle
tumor dephosphorylation
tumor factors
tumor gene
tumorigenesis mechanisms
tumorigenesis Rb1
tumorigenicity cancer
tumor incidence
tumor node
tumor outcomes
tumor PIK3CA
tumor pRb
tumor proliferation
tumor promoter
tumor protein
tumor Ras
tumor regressions
tumor retinoblastoma
tumors E2F1
tumors modeling
tumors OCT
tumors outcomes
tumor spectrum
tumors penetrance
tumors periphery
tumors Rb
tumors Rb1
tumors thyroid
tumors tumors
tumor suppressive
tumor suppressor
tumor suppressors
tumor susceptibility
tumor vivo
turnover interactions
type-specific genes
types tissues
types VCAM-1
ubiquitination ligase
ubiquitination SCF
ubiquitination ubiquitin
ubiquitin ligase
ubiquitin ligases
ubiquitin RB
UL97-L1m Rb
UL97-mediated phosphorylation
UL97-mediated Rb
UL97 motifs
UL97 protein
UL97 Rb
upregulation D1
up-regulation DNMT1
up-regulation DNMT3b
upregulation p16
upregulation phosphorylation
VCAM-1 endothelium
ventricular cardiomyocyte
venules capillaries
viability apoptosis
viability cycle
vitro U-box
vitro vivo
vivo electroporation
vivo retinas
X-ray radiation
β galactosidase
